Candia, Teresita R.
HRN: 27-10-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2026
01/14/2026
IV
600mg
Q6
Nonhealing Wound
Checking Initial Appropriateness
01/08/2026
MUPIROCIN 2%, 15G (TUBE)
01/08/2026
01/14/2026
TOPICAL
15g
BID
Non-healing Wound
Checking Initial Appropriateness
01/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/09/2026
01/09/2026
IV
4.5g
Loading Dose
Dm Foot
Checking Initial Appropriateness
01/09/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/09/2026
01/16/2026
IVT
2.25g
Q6
Dm Foot
Checking Initial Appropriateness